Expression of the novel human gene, UBE2Q1, in breast tumors

Molecular Biology Reports

Volumn 39, Issue 5, 2012, Pages 5135-5141

  Seghatoleslam, Atefeh ^a   Nikseresht, Mohsen ^b   Shafiee, Sayed Mohammad ^a   Monabati, Ahmad ^a   Namavari, Mohammad Mehdi ^c   Talei, Abdolrassul ^a   Safaei, Akbar ^a   Owji, Ali Akbar ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b YASUJ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c RAZI VACCINE AND SERUM RESEARCH INSTITUTE   (Iran)

Author keywords

Breast cancer; Expression; UBE2Q1

Indexed keywords

MESSENGER RNA; POLYCLONAL ANTIBODY; TUMOR PROTEIN; UBIQUITIN CONJUGATING ENZYME E2Q FAMILY MEMBER 1 PROTEIN; UNCLASSIFIED DRUG; CANCER ANTIBODY; UBIQUITIN CONJUGATING ENZYME;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; BREAST CANCER; CARBOXY TERMINAL SEQUENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE STRUCTURE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC CODE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MOLECULAR PATHOLOGY; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PREDICTION; PROTEIN DOMAIN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY; TUMOR GENE; TUMOR VOLUME; UBIQUITIN CONJUGATING ENZYME E2Q FAMILY MEMBER 1 GENE; WESTERN BLOTTING; ANIMAL; BREAST; BREAST TUMOR; ENZYMOLOGY; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; RABBIT;

ORYCTOLAGUS CUNICULUS;

ADULT; AGED; ANIMALS; ANTIBODIES, NEOPLASM; BREAST; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; RABBITS; RNA, MESSENGER; UBIQUITIN-CONJUGATING ENZYMES;

EID: 84863735317     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-1309-x     Document Type: Article

References (41)

1. Vogelstein B, Kinzler KW (1994) Has the breast cancer gene been found? Cell 79:1-3
2. Coughlin SS, Ekwueme DU (2009) Breast cancer as a global health concern. Cancer Epidemiol 33:315-318
3. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D (2000) Molecular portraits of human breast tumours. Nature 406:747-752
4. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S, Demeter J, Perou CM, Lonning PE, Brown PO, Borresen-Dale AL, Botstein D (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 100: 8418-8423
5. Sotiriou C, Neo SY, McShane LM, Korn EL, Long PM, Jazaeri A, Martiat P, Fox SB, Harris AL, Liu ET (2003) Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci USA 100:10393-10398
6. Sotiriou C, Wirapati P, Loi S, Harris A, Fox S, Smeds J, Nordgren H, Farmer P, Praz V, Haibe-Kains B, Desmedt C, Larsimont D, Cardoso F, Peterse H, Nuyten D, Buyse M, Van de Vijver MJ, Bergh J, Piccart M, Delorenzi M (2006) Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst 98:262-272
7. Lin J, Gan CM, Zhang X, Jones S, Sjoblom T, Wood LD, Parsons DW, Papadopoulos N, Kinzler KW, Vogelstein B, Parmigiani G, Velculescu VE (2007) A multidimensional analysis of genes mutated in breast and colorectal cancers. Genome Res 17: 1304-1318
8. Ohta T, Fukuda M (2004) Ubiquitin and breast cancer. Oncogene 23:2079-2088
9. Welchman RL, Gordon C, Mayer RJ (2005) Ubiquitin and ubiquitin-like proteins as multifunctional signals. Natl Rev Mol Cell Biol 6:599-609
10. Yang WL, Wu CY, Wu J, Lin HK (2010) Regulation of Akt signaling activation by ubiquitination. Cell Cycle 9:487-497
11. Margolis RN, Christakos S (2010) The nuclear receptor superfamily of steroid hormones and vitamin D gene regulation. An update. Ann NY Acad Sci 1192:208-214
12. Dennis AP, Haq RU, Nawaz Z (2001) Importance of the regulation of nuclear receptor degradation. Front Biosci 6:D954-D959
13. Selvarajah J, Moumen A (2010) Role of ubiquitination in the DNA damage response: proteomic analysis to identify new DNAdamage-induced ubiquitinated proteins. Biochem Soc Trans 38:87-91
14. Wickliffe K, Williamson A, Jin L, Rape M (2009) The multiple layers of ubiquitin-dependent cell cycle control. Chem Rev 109:1537-1548
15. Chen D, Kon N, Li M, Zhang W, Qin J, Gu W (2005) ARF-BP1/ Mule is a critical mediator of the ARF tumor suppressor. Cell 121:1071-1083
16. Yang Y, Yu X (2003) Regulation of apoptosis: the ubiquitous way. FASEB J 17:790-799
17. Lee JT, Gu W (2010) The multiple levels of regulation by p53 ubiquitination. Cell Death Differ 17:86-92
18. Muller J, Eilers M (2008) Ubiquitination of Myc: proteasomal degradation and beyond. Ernst Schering Found Symp Proc (1):99-113
19. Wei W, Jin J, Schlisio S, Harper JW, Kaelin WG Jr (2005) The v-Jun point mutation allows c-Jun to escape GSK3-dependent recognition and destruction by the Fbw7 ubiquitin ligase. Cancer Cell 8:25-33
20. Lipkowitz S (2003) The role of the ubiquitination-proteasome pathway in breast cancer: ubiquitin mediated degradation of growth factor receptors in the pathogenesis and treatment of cancer. Breast Cancer Res 5:8-15
21. Mani A, Gelmann EP (2005) The ubiquitin-proteasome pathway and its role in cancer. J Clin Oncol 23:4776-4789
22. Seghatoleslam A, Zambrano A, Millon R, Ganguli G, Argentini M, Cromer A, Abecassis J, Wasylyk B (2006) Analysis of a novel human gene, LOC92912, over-expressed in hypopharyngeal tumours. Biochem Biophys Res Commun 339:422-429
23. Nikseresht M, Seghatoleslam A, Monabati A, Talei A, Ghalati FB, Owji AA (2010) Overexpression of the novel human gene, UBE2Q2, in breast cancer. Cancer Genet Cytogenet 197:101-106
24. Jarzabek K, Koda M, Kozlowski L, Mittre H, Sulkowski S, Kottler ML, Wolczynski S (2005) Distinct mRNA, protein expression patterns and distribution of oestrogen receptors alpha and beta in human primary breast cancer: correlation with proliferation marker Ki-67 and clinicopathological factors. Eur J Cancer 41:2924-2934
25. Bieche I, Champeme MH, Lidereau R (1995) Loss and gain of distinct regions of chromosome 1q in primary breast cancer. Clin Cancer Res 1:123-127
26. Burger AM, Gao Y, Amemiya Y, Kahn HJ, Kitching R, Yang Y, Sun P, Narod SA, Hanna WM, Seth AK (2005) A novel RINGtype ubiquitin ligase breast cancer-associated gene 2 correlates with outcome in invasive breast cancer. Cancer Res 65: 10401-10412
27. Rennstam K, Ahlstedt-Soini M, Baldetorp B, Bendahl PO, Borg A, Karhu R, Tanner M, Tirkkonen M, Isola J (2003) Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization. Cancer Res 63:8861-8868
28. Callahan R, Cropp CS, Merlo GR, Liscia DS, Cappa AP, Lidereau R (1992) Somatic mutations and human breast cancer. A status report. Cancer 69:1582-1588
29. Gregory SG, Barlow KF, McLay KE, Kaul R, Swarbreck D, Dunham A, Scott CE, Howe KL, Woodfine K, Spencer CC, Jones MC, Gillson C, Searle S, Zhou Y, Kokocinski F, McDonald L, Evans R, Phillips K, Atkinson A, Cooper R, Jones C, Hall RE, Andrews TD, Lloyd C, Ainscough R, Almeida JP, Ambrose KD, Anderson F, Andrew RW, Ashwell RI, Aubin K, Babbage AK, Bagguley CL, Bailey J, Beasley H, Bethel G, Bird CP, Bray-Allen S, Brown JY, Brown AJ, Buckley D, Burton J, Bye J, Carder C, Chapman JC, Clark SY, Clarke G, Clee C, Cobley V, Collier RE, Corby N, Coville GJ, Davies J, Deadman R, Dunn M, Earthrowl M, Ellington AG, Errington H, Frankish A, Frankland J, French L, Garner P, Garnett J, Gay L, Ghori MR, Gibson R, Gilby LM, Gillett W, Glithero RJ, Grafham DV, Griffiths C, Griffiths-Jones S, Grocock R, Hammond S, Harrison ES, Hart E, Haugen E, Heath PD, Holmes S, Holt K, Howden PJ, Hunt AR, Hunt SE, Hunter G, Isherwood J, James R, Johnson C, Johnson D, Joy A, Kay M, Kershaw JK, Kibukawa M, Kimberley AM, King A, Knights AJ, Lad H, Laird G, Lawlor S, Leongamornlert DA, Lloyd DM, Loveland J, Lovell J, Lush MJ, Lyne R, Martin S, Mashreghi-Mohammadi M, Matthews L, Matthews NS, McLaren S, Milne S, Mistry S, Moore MJ, Nickerson T, O'Dell CN, Oliver K, Palmeiri A, Palmer SA, Parker A, Patel D, Pearce AV, Peck AI, Pelan S, Phelps K, Phillimore BJ, Plumb R, Rajan J, Raymond C, Rouse G, Saenphimmachak C, Sehra HK, Sheridan E, Shownkeen R, Sims S, Skuce CD, Smith M, Steward C, Subramanian S, Sycamore N, Tracey A, Tromans A, Van Helmond Z, Wall M, Wallis JM, White S, Whitehead SL, Wilkinson JE, Willey DL, Williams H, Wilming L, Wray PW, Wu Z, Coulson A, Vaudin M, Sulston JE, Durbin R, Hubbard T, Wooster R, Dunham I, Carter NP, McVean G, Ross MT, Harrow J, Olson MV, Beck S, Rogers J, Bentley DR, Banerjee R, Bryant SP, Burford DC, Burrill WD, Clegg SM, Dhami P, Dovey O, Faulkner LM, Gribble SM, Langford CF, Pandian RD, Porter KM, Prigmore E (2006) The DNA sequence and biological annotation of human chromosome 1. Nature 441:315-321
30. Koon N, Zaika A, Moskaluk CA, Frierson HF, Knuutila S, Powell SM, El-Rifai W (2004) Clustering of molecular alterations in gastroesophageal carcinomas. Neoplasia 6:143-149
31. Maru DM, Luthra R, Correa AM, White-Cross J, Anandasabapathy S, Krishnan S, Guha S, Komaki R, Swisher SG, Ajani JA, Hofstetter WL, Rashid A (2009) Frequent loss of heterozygosity of chromosome 1q in esophageal adenocarcinoma: loss of chromosome 1q21.3 is associated with shorter overall survival. Cancer 115:1576-1585
32. Doerks T, Copley RR, Schultz J, Ponting CP, Bork P (2002) Systematic identification of novel protein domain families associated with nuclear functions. Genome Res 12:47-56
33. http://smart.embl-heidelberg.de/smart/do-annotation.pl?DOMAIN= RWD
34. Nameki N, Yoneyama M, Koshiba S, Tochio N, Inoue M, Seki E, Matsuda T, Tomo Y, Harada T, Saito K, Kobayashi N, Yabuki T, Aoki M, Nunokawa E, Matsuda N, Sakagami N, Terada T, Shirouzu M, Yoshida M, Hirota H, Osanai T, Tanaka A, Arakawa T, Carninci P, Kawai J, Hayashizaki Y, Kinoshita K, Guntert P, Kigawa T, Yokoyama S (2004) Solution structure of the RWD domain of the mouse GCN2 protein. Protein Sci 13:2089-2100
35. Hicke L, Schubert HL, Hill CP (2005) Ubiquitin-binding domains. Natl Rev Mol Cell Biol 6:610-621
36. Yoder BJ, Wilkinson EJ, Massoll NA (2007) Molecular and morphologic distinctions between infiltrating ductal and lobular carcinoma of the breast. Breast J 13:172-179
37. van Wijk SJ, Timmers HT (2010) The family of ubiquitin-conjugating enzymes (E2 s): deciding between life and death of proteins. FASEB J 24:981-993
38. http://www.ncbi.nlm.nih.gov/geoprofiles?term=UBE2Q1%20GDS3139
39. Hall A (2009) The cytoskeleton and cancer. Cancer Metastasis Rev 28:5-14
40. Wassler MJ, Shur BD, Zhou W, Geng YJ (2008) Characterization of a novel ubiquitin-conjugating enzyme that regulates beta1, 4-galactosyltransferase-1 in embryonic stem cells. Stem Cells 26:2006-2018
41. Seghatoleslam A, Zambreno A (2009) Effects of over-expression of LOC92912 gene on cell cycle progression. Iranian J Med Sci 34:277-284